Skip to content
MMJ Gazette
  Sunday 21 December 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
December 20, 2025Trump Signs Order to Reclassify Cannabis, Sparking Industry Shift December 19, 2025New Jersey Bill Allows Hemp THC Drinks in Liquor Stores December 18, 2025PharmaCann Strikes $49M Deal to Sell Colorado Assets to Vireo December 17, 2025Connecticut Cannabis Prices Keep Falling in November December 16, 2025Trump Eyes Major Shift in Cannabis Rules December 10, 2025New York Cannabis Boss Quits Amid Massive Probe Failure December 9, 2025Florida’s Medical Marijuana Patient Growth Slows in 2025 December 6, 2025California and New York Cannabis Brands Battle for Glory: Winners Revealed at First MJBowl December 5, 2025Minnesota Cannabis Market Hits Roadblock with Transporter Shortage December 4, 2025Verano CEO Eyes Big Changes for Weed Business at MJBizCon
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Marijuana  U.S. Court of Appeals Upholds Virginia Total THC Hemp Law
MarijuanaNews

U.S. Court of Appeals Upholds Virginia Total THC Hemp Law

Lars BeckersLars Beckers—January 28, 20250
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

A U.S. appeals court has upheld a Virginia law that strictly regulates hemp products based on total THC content, solidifying the state’s authority over hemp regulation within its borders. The decision has significant implications for businesses and consumers in Virginia’s hemp industry.

What the Virginia Law Entails

Virginia’s hemp law, enacted in 2023, sets stringent limits on the amount of THC allowed in hemp products. Under this law, hemp products cannot exceed 0.3% THC, regardless of whether the compound is delta-9, delta-8, or any other form of THC. This contrasts with previous practices in many states, which primarily focused on delta-9 THC, the most well-known psychoactive compound in cannabis.

The regulation is part of a broader push to tighten control over hemp-derived products, particularly delta-8 THC, which gained popularity as a legal alternative to marijuana in some jurisdictions. However, delta-8 THC’s psychoactive effects have sparked concerns among lawmakers and regulators, leading to measures like Virginia’s law.

The Lawsuit and Key Arguments

The plaintiffs in the case—Northern Virginia Hemp and Agriculture LLC (NOVA Hemp), Franny’s Operations, Inc. (Franny’s Farmacy), and Virginia resident Rose Lane—challenged the law on several grounds. They argued that:

  1. Federal Preemption: The plaintiffs claimed that the 2018 federal Farm Bill, which legalized hemp and its derivatives with less than 0.3% delta-9 THC, preempted Virginia’s stricter standards.
  2. Dormant Commerce Clause: They also argued that the law violated the Dormant Commerce Clause of the U.S. Constitution by creating barriers to interstate commerce and unfairly discriminating against out-of-state hemp producers.

How the Court Responded

The U.S. Court of Appeals for the Fourth Circuit rejected both arguments, affirming the district court’s decision in favor of the Virginia law. Here’s how the court addressed the key points:

  • Federal Preemption: The court ruled that federal law does not prohibit states from regulating the sale of hemp products within their own borders. While the Farm Bill sets a baseline for hemp legality, it also leaves room for states to impose their own rules. The court noted that Virginia’s law fits within this framework, as it regulates sales rather than cultivation.
  • Dormant Commerce Clause: On this issue, the court found no evidence that the law discriminates against out-of-state producers. It emphasized that the regulation applies equally to all hemp products, regardless of origin, and does not impose an undue burden on interstate commerce.

Implications for Hemp Businesses

For businesses operating in Virginia, this ruling cements the state’s authority to regulate hemp more stringently than federal law. Companies that produce or sell hemp products will need to comply with Virginia’s total THC limits, which may involve additional testing and reformulation of products.

This decision may also discourage other states from relying solely on the federal Farm Bill’s standards, potentially leading to a patchwork of state regulations that businesses must navigate. Producers who operate in multiple states could face increased costs and logistical challenges.

  • Key Takeaways for Businesses:
    • Products sold in Virginia must contain no more than 0.3% total THC, regardless of the type.
    • Compliance with state-specific regulations will be critical to avoid penalties.
    • Businesses may need to invest in better testing and product development to meet varying state standards.

Broader Impact on the Hemp Industry

This ruling highlights an ongoing debate in the hemp and cannabis industries: the balance of power between federal and state regulation. While the Farm Bill legalized hemp federally, states continue to assert their authority to regulate its sale and distribution within their borders.

The court’s decision also underscores the growing scrutiny of delta-8 THC, a compound that has been both a boon and a headache for the hemp industry. As states like Virginia crack down on delta-8 and other forms of THC, businesses may find it increasingly challenging to market these products without running afoul of the law.

A Split Landscape for Regulation

Virginia’s law and the Fourth Circuit’s decision illustrate the fragmented nature of hemp and cannabis regulation in the U.S. While some states have embraced looser rules, others are tightening restrictions. This regulatory patchwork creates uncertainty for the industry and may ultimately push for more unified federal guidelines.

Still, for now, Virginia’s decision to regulate total THC levels reflects a growing trend among states to take a harder line on hemp-derived THC products. Businesses and consumers alike will need to keep a close eye on these developments as the regulatory landscape continues to shift.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Explosion at PharmaCann Facility in Maryland Leaves Two Injured
Massachusetts Cannabis Industry Sets $1.64B Annual Sales Record in 2024
Related posts
  • Related posts
  • More from author
Cannabis

Trump Signs Order to Reclassify Cannabis, Sparking Industry Shift

December 20, 20250
Cannabis

New Jersey Bill Allows Hemp THC Drinks in Liquor Stores

December 19, 20250
Cannabis

PharmaCann Strikes $49M Deal to Sell Colorado Assets to Vireo

December 18, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Trump Signs Order to Reclassify Cannabis, Sparking Industry Shift
  • New Jersey Bill Allows Hemp THC Drinks in Liquor Stores
  • PharmaCann Strikes $49M Deal to Sell Colorado Assets to Vireo
  • Connecticut Cannabis Prices Keep Falling in November
  • Trump Eyes Major Shift in Cannabis Rules
  • New York Cannabis Boss Quits Amid Massive Probe Failure
  • Florida’s Medical Marijuana Patient Growth Slows in 2025
  • California and New York Cannabis Brands Battle for Glory: Winners Revealed at First MJBowl
  • Minnesota Cannabis Market Hits Roadblock with Transporter Shortage
  • Verano CEO Eyes Big Changes for Weed Business at MJBizCon
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors